Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04694534 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Remediation Program Via a "Serious Game" for the Cognitive Functions of Multiple Sclerosis Patients

Study acronym: E-SEP
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 4, 2025 (before its estimated April 4, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion date: Apr 4, 2025 to Apr 4, 2026
    • Study completion date: Mar 1, 2026 to Mar 1, 2027
    v7
  2. Minor Study sites revised (6)v6
  3. Minor Primary completion date: Mar 1, 2026 to Apr 4, 2025v5
  4. Notable Primary and study completion dates: Mar 1, 2024 to Mar 1, 2026
    • Study sites revised (6)
    v4
  5. Minor Re-verified, no change to tracked fieldsv3
  6. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Aug 1, 2023 to Mar 1, 2024
    • Start date changed from estimate of Mar 1, 2021 to Oct 8, 2021
    • Study sites: 1 to 6
    v2
  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main goal of this study is to assess the effectiveness of a cognitive remediation program based on a "serious game" on the information processing speed evolution and the process of learning via episodic memory in multiple sclerosis patients.
Trial Details
NCT Number NCT04694534
Lead Sponsor Lille Catholic University
Conditions
(from sponsor)
Multiple Sclerosis, Memory, Learning
Related terms Multiple Sclerosis
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov